Cipla Seeks Shareholder Nod for Achin Gupta as New CEO

Introduction

Cipla Limited, a leading Indian pharmaceutical company, has initiated a postal ballot to seek shareholder approval for key leadership changes. The primary proposal involves the appointment of Achin Gupta as the new Managing Director and Global Chief Executive Officer, effective April 1, 2026. This move is part of a structured succession plan as the company continues to strengthen its global operations and drive operational efficiency.

The Shareholder Voting Process

Shareholders are invited to vote on several resolutions through a remote e-voting process. The voting period is scheduled to commence at 9:00 AM on February 24, 2026, and will conclude at 5:00 PM on March 25, 2026. The company has set February 20, 2026, as the cut-off date for determining eligible shareholders. The results of the postal ballot are expected to be announced on or before March 30, 2026. The notice has been sent electronically to all eligible members, and the company has appointed BNP & Associates as the scrutinizer to oversee the e-voting process.

Key Resolutions for Approval

The postal ballot includes four main resolutions that require shareholder consent. These resolutions cover the appointment and remuneration of the new MD & Global CEO, as well as the re-appointment of an independent director.

Proposed Executive Compensation

A significant part of the proposal is the detailed remuneration package for Achin Gupta for his five-year term, from April 1, 2026, to March 31, 2031. The compensation structure is designed to align with the company's performance and long-term growth.

Profile of the Incoming Leader

Achin Gupta currently serves as the Global Chief Operating Officer at Cipla, a role he assumed in February 2025. He joined the company in 2021 as the CEO of the One India Business. Under his leadership, the India business saw significant revenue growth and solidified its number one position in the Indian pharmaceutical market by volume. Gupta holds an M.Tech in Biochemical Engineering and Biotechnology from IIT Delhi and an MBA from IIM Ahmedabad. His extensive experience is expected to guide Cipla through its next phase of expansion and innovation.

Re-appointment of Independent Director

Shareholders will also vote on a special resolution to re-appoint Mr. P R Ramesh as an Independent Director for a second five-year term, effective from July 1, 2026, to June 30, 2031. A special resolution is required as Mr. Ramesh will attain the age of 75 during his proposed second term, in compliance with SEBI regulations. Mr. Ramesh is a Fellow Member of the ICAI with over four decades of professional experience, including his previous role as a Director at Deloitte & Touche.

Market Context and Strategic Importance

This leadership transition comes at a pivotal time for Cipla as it navigates global pricing pressures and regulatory changes while focusing on expansion in key markets like the US and Europe. The company has demonstrated strong financial performance, reporting its highest-ever quarterly revenue of Rs 7,589 crore in Q2 FY2026. The appointment of Achin Gupta is seen as a strategic move to ensure continuity and build on the company's growth momentum. However, the company's stock has seen volatility over the past year.

Conclusion

The proposed appointment of Achin Gupta marks a significant step in Cipla's long-term succession planning. The decision now rests with the shareholders, whose votes during the month-long e-voting window will determine the future leadership of the company. The outcome of the postal ballot, to be declared by the end of March 2026, will be closely watched by the market and industry stakeholders.